These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 80193)

  • 1. Binding of anti-mitotic drugs to cysteine residues of tubulin [proceedings].
    Schmitt H; Kram R
    Arch Int Physiol Biochim; 1978 Feb; 86(1):212-3. PubMed ID: 80193
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of antimitotic drugs around cysteine residues of tubulin.
    Schmitt H; Kram R
    Exp Cell Res; 1978 Sep; 115(2):408-11. PubMed ID: 689096
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B; Panda D; Gupta S; Banerjee M
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of maytansine to tubulin: competition with other mitotic inhibitors.
    Lin CM; Hamel E; Wolpert-DeFilippes MK
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):443-51. PubMed ID: 7255878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
    Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulin binding affinities of podophyllotoxin and colchicine analogues.
    Kelleher JK
    Mol Pharmacol; 1977 Mar; 13(2):232-41. PubMed ID: 854021
    [No Abstract]   [Full Text] [Related]  

  • 8. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric measurement of differential reactivity of cysteine to localize protein-ligand binding sites. Application to tubulin-binding drugs.
    Kim YJ; Pannell LK; Sackett DL
    Anal Biochem; 2004 Sep; 332(2):376-83. PubMed ID: 15325307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proceedings: Morphological changes and adherence speed of L cells treated with anti mitotic agents].
    Doi A; Murakami T; Nishida I
    Nihon Seirigaku Zasshi; 1974 Sep; 36(8-9):345. PubMed ID: 4478474
    [No Abstract]   [Full Text] [Related]  

  • 11. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms.
    Mane JY; Klobukowski M; Huzil JT; Tuszynski J
    J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
    Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
    Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of colchicine and some related alkaloids with rat brain tubulin.
    McClure WO; Paulson JC
    Mol Pharmacol; 1977 May; 13(3):560-75. PubMed ID: 559920
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural basis for the regulation of tubulin by vinblastine.
    Gigant B; Wang C; Ravelli RB; Roussi F; Steinmetz MO; Curmi PA; Sobel A; Knossow M
    Nature; 2005 May; 435(7041):519-22. PubMed ID: 15917812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinblastine inhibition of microtubule assembly in vitro.
    Sajó I
    Acta Biochim Biophys Acad Sci Hung; 1977; 12(3):259-61. PubMed ID: 602674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs.
    Kelleher JK
    Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain colchicine-binding protein (tubulin) during postnatal development in the rat.
    Gonzales LW; Geel SE
    J Neurosci Res; 1976; 2(5-6):373-84. PubMed ID: 1028853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of experimental colchicine encephalopathy on brain protein synthesis and tubulin metabolism.
    McMartin DN; Schedlbauer LM
    J Neurobiol; 1978 Nov; 9(6):453-63. PubMed ID: 84049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
    Wang RW; Rebhum LI; Kupchan SM
    Cancer Res; 1977 Sep; 37(9):3071-9. PubMed ID: 560248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological characteristics of microtubule and related drug research].
    Li JN; Jiang JD
    Yao Xue Xue Bao; 2003 Apr; 38(4):311-5. PubMed ID: 12889136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.